Small cap biotech companies spend hundreds of millions of dollars and over ten years moving experimental drug candidates from concept to fully approved drugs. For late stage drug candidates, those in Phase III, positive or negative data can result in either massive gains or devastating declines in the sponsoring company's stock price. This "ultimate catalyst event" provides smart, organized & nimble option traders spectacular & consistent trading opportunities. In this unique book, the author provides individuals unfamiliar with the world of small cap biotech a fast, simplified and efficient approach to identify, analyze & execute trading strategies using options. The following topics, amongst others, are covered in this book: * Description of the FDA drug trial process, from pre-clinical to Phase III & beyond * Identification, categorization & organization of small cap biotech companies * Structured & streamlined approach to assess small cap biotech companies * Notes on trading strategy & tactics * Detailed description of option trading structures best suited for small cap biotech This book is an absolute "must have" for individuals thinking about trading in the fast paced and often confusing world of small cap biotech.
"synopsis" may belong to another edition of this title.
T. Ayers Pelz was a trader on a major European bank's proprietary trading desk. He was responsible for a portfolio with limits of more than $200 million. Prior to proprietary trading, Mr. Pelz worked with several major investment banks in roles ranging from corporate finance, mergers and acquisitions to credit and business development. He has substantial international work experience in Asia, U.S., Europe and Latin America and was based in New York City, Bogotá (Colombia), Rio de Janeiro (Brazil) and Amsterdam (The Netherlands). Mr. Pelz currently resides in Denver, Colorado where he trades for his own account. He is married and has a young son.
"About this title" may belong to another edition of this title.
FREE shipping within U.S.A.
Destination, rates & speedsSeller: -OnTimeBooks-, Phoenix, AZ, U.S.A.
Condition: acceptable. Reading copy. May have signs of wear and previous use scuffs, library copy, highlighting, writing, and underlining . Dust jacket may be missing. 100% GUARANTEE! Shipped with delivery confirmation, if youâre not satisfied with purchase.Ships USPS Media Mail. Seller Inventory # OTV.1450598536.A
Quantity: 1 available
Seller: Sunshine State Books, Lithia, FL, U.S.A.
paperback. Condition: As New. Paperback--no flaws. Seller Inventory # SF250312009G223
Quantity: 1 available
Seller: clickgoodwillbooks, Indianapolis, IN, U.S.A.
Condition: acceptable. Used - Acceptable: All pages and the cover are intact, but shrink wrap, dust covers, or boxed set case may be missing. Pages may include limited notes, highlighting, or minor water damage but the text is readable. Item may be missing bundled media. Seller Inventory # 3O6WBH000CLA_ns
Quantity: 1 available
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New. Seller Inventory # 9630756-n
Quantity: Over 20 available
Seller: Treasure Island, Waltham, MA, U.S.A.
paperback. Condition: New. Seller Inventory # 53HN5000011O
Quantity: 1 available
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: As New. Unread book in perfect condition. Seller Inventory # 9630756
Quantity: Over 20 available
Seller: THE SAINT BOOKSTORE, Southport, United Kingdom
Paperback / softback. Condition: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days 320. Seller Inventory # C9781450598538
Quantity: Over 20 available
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: New. Seller Inventory # 9630756-n
Quantity: Over 20 available
Seller: CitiRetail, Stevenage, United Kingdom
Paperback. Condition: new. Paperback. Small cap biotech companies spend hundreds of millions of dollars and over ten years moving experimental drug candidates from concept to fully approved drugs. For late stage drug candidates, those in Phase III, positive or negative data can result in either massive gains or devastating declines in the sponsoring company's stock price. This "ultimate catalyst event" provides smart, organized & nimble option traders spectacular & consistent trading opportunities. In this unique book, the author provides individuals unfamiliar with the world of small cap biotech a fast, simplified and efficient approach to identify, analyze & execute trading strategies using options. The following topics, amongst others, are covered in this book: * Description of the FDA drug trial process, from pre-clinical to Phase III & beyond * Identification, categorization & organization of small cap biotech companies * Structured & streamlined approach to assess small cap biotech companies * Notes on trading strategy & tactics * Detailed description of option trading structures best suited for small cap biotech This book is an absolute "must have" for individuals thinking about trading in the fast paced and often confusing world of small cap biotech. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. Seller Inventory # 9781450598538
Quantity: 1 available
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: As New. Unread book in perfect condition. Seller Inventory # 9630756
Quantity: Over 20 available